AVAILABLE INFORMATION FOR
(EUREPA V 1/0.3 TABLET)

SALT INFORMATION
Repaglinide 1 MG + Voglibose 0.3 MG

REPAGLINIDE 1 MG
Use
Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in Type 2 Diabetes Mellitus.
Common Side Effect
Low blood sugar, Abdominal pain, Nausea, Diarrhoea, Headache.
Precaution
Precaution should be taken in people with liver disease and decreased kidney function when using this medication.
Class of Drug - Anti-diabetic Drug (Meglitinides Class)
Route of Administration - Oral
Bioavailability - 56% Oral
Elimination Halflife - 1 Hours
Excretion - Fecal 90%, Renal (8%)

VOGLIBOSE 0.3 MG
Use
It is used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It delays the absorption of glucose thereby reducing the risk of macrovascular complications.
Common Side Effects
Includes blurred vision, feeling of sickness, feeling of discomfort, increased intestinal gas, numbness, abdominal pain.
Precautions
It should be used with caution in patient with liver diseases and renal function impairment.
Class of Drug - Alpha Glucosidase Inhibitor
Route of Administration - Oral
Excretion - Renal 90%